Follow
Prashanthi Dharanipragada, Ph.D
Prashanthi Dharanipragada, Ph.D
Postdoctoral researcher, UCLA Health
Verified email at mednet.ucla.edu
Title
Cited by
Cited by
Year
iCopyDAV: Integrated platform for copy number variations—Detection, annotation and visualization
P Dharanipragada, S Vogeti, N Parekh
PLoS One 13 (4), e0195334, 2018
522018
Targeted profiling of human extrachromosomal DNA by CRISPR-CATCH
KL Hung, J Luebeck, SR Dehkordi, CI Colón, R Li, ITL Wong, C Coruh, ...
Nature genetics 54 (11), 1746-1754, 2022
492022
Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges
K Song, JK Minami, A Huang, SR Dehkordi, SH Lomeli, J Luebeck, ...
Cancer discovery 12 (4), 1046-1069, 2022
382022
Blocking genomic instability prevents acquired resistance to MAPK inhibitor therapy in melanoma
P Dharanipragada, X Zhang, S Liu, SH Lomeli, A Hong, Y Wang, Z Yang, ...
Cancer discovery 13 (4), 880-909, 2023
242023
Multi-organ landscape of therapy-resistant melanoma
S Liu, P Dharanipragada, SH Lomeli, Y Wang, X Zhang, Z Yang, RJ Lim, ...
Nature medicine 29 (5), 1123-1134, 2023
82023
SeqVItA: Sequence variant identification and annotation platform for next generation sequencing data
P Dharanipragada, SR Seelam, N Parekh
Frontiers in Genetics 9, 413951, 2018
62018
Genome-wide characterization of copy number variations in diffuse large B-cell lymphoma with implications in targeted therapy
P Dharanipragada, N Parekh
Precision Clinical Medicine 2 (4), 246-258, 2019
52019
Copy number variation detection workflow using next generation sequencing data
P Dharanipragada, N Parekh
2016 International Conference on Bioinformatics and Systems Biology (Bsb), 1-5, 2016
42016
Abstract LB251: Blocking genomic instability delays acquired resistance to MAPK inhibitor therapy in melanoma
P Dharanipragada, X Zhang, S Liu, SH Lomeli, A Hong, Y Wang, Z Yang, ...
Cancer Research 83 (8_Supplement), LB251-LB251, 2023
2023
In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines
P Dharanipragada, N Parekh
Cells 12 (4), 596, 2023
2023
Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
K Manna, P Dharanipragada, D Alkam, NL Avaritt, CL Washam, ...
bioRxiv, 2022.02. 15.480454, 2022
2022
Detection and Functional Characterization of Genetic Variations in Diffuse Large B cell Lymphoma
P Dharanipragada
International Institute of Information Technology, Hyderabad, 2020
2020
Identifying Biomarkers for Diffuse Large B-Cell Lymphoma Subtypes
P Dharanipragada, N Parekh
Novel Approaches in Cancer Study 3 (2), 260-262, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–13